These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21477946)

  • 21. Radiobiologic comparison of helical tomotherapy, intensity modulated radiotherapy, and conformal radiotherapy in treating lung cancer accounting for secondary malignancy risks.
    Komisopoulos G; Mavroidis P; Rodriguez S; Stathakis S; Papanikolaou N; Nikiforidis GC; Sakellaropoulos GC
    Med Dosim; 2014; 39(4):337-47. PubMed ID: 25168596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of dose-volume parameters predicting radiation pneumonitis in patients with esophageal cancer treated with 3D-conformal radiation therapy or IMRT.
    Kumar G; Rawat S; Puri A; Sharma MK; Chadha P; Babu AG; Yadav G
    Jpn J Radiol; 2012 Jan; 30(1):18-24. PubMed ID: 22160648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy.
    Song CH; Pyo H; Moon SH; Kim TH; Kim DW; Cho KH
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):651-8. PubMed ID: 20207499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propensity score-based comparison of survival and radiation pneumonitis after definitive chemoradiation for esophageal cancer: Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy.
    Lan K; Zhu J; Zhang J; Zhou S; Yang Y; Feng Z; Zhang L; Wang S; Xi M
    Radiother Oncol; 2020 Aug; 149():228-235. PubMed ID: 32474127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung Cancer.
    Ling DC; Hess CB; Chen AM; Daly ME
    Clin Lung Cancer; 2016 Jan; 17(1):18-23. PubMed ID: 26303127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis.
    Fleckenstein J; Eschler A; Kremp K; Kremp S; Rübe C
    Radiat Oncol; 2015 Aug; 10():178. PubMed ID: 26292716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
    Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.
    Choi Y; Kim JK; Lee HS; Hur WJ; Chai GY; Kang KM
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):683-9. PubMed ID: 15927412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Shi A; Zhu G; Wu H; Yu R; Li F; Xu B
    Radiat Oncol; 2010 May; 5():35. PubMed ID: 20462424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity.
    Landry JC; Yang GY; Ting JY; Staley CA; Torres W; Esiashvili N; Davis LW
    Med Dosim; 2002; 27(2):121-9. PubMed ID: 12074463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New dose constraint reduces radiation-induced fatal pneumonitis in locally advanced non-small cell lung cancer patients treated with intensity-modulated radiotherapy.
    Khalil AA; Hoffmann L; Moeller DS; Farr KP; Knap MM
    Acta Oncol; 2015; 54(9):1343-9. PubMed ID: 26198657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin's lymphoma.
    Pepper NB; Oertel M; Kittel C; Kröger KJ; Elsayad K; Haverkamp U; Eich HT
    Strahlenther Onkol; 2021 Jan; 197(1):56-62. PubMed ID: 32945894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
    Piotrowski T; Matecka-Nowak M; Milecki P
    Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simple method for evaluating achievement degree of lung dose optimization in individual patients with locally advanced non-small cell lung cancer treated with intensity modulated radiotherapy.
    Abe T; Iino M; Saito S; Aoshika T; Ryuno Y; Ohta T; Igari M; Hirai R; Kumazaki Y; Miura Y; Kaira K; Kagamu H; Noda S; Kato S
    Thorac Cancer; 2022 Oct; 13(20):2890-2896. PubMed ID: 36054298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning.
    Fleckenstein J; Kremp K; Kremp S; Palm J; Rübe C
    Strahlenther Onkol; 2016 Feb; 192(2):75-82. PubMed ID: 26438071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spatial Dose Patterns Associated With Radiation Pneumonitis in a Randomized Trial Comparing Intensity-Modulated Photon Therapy With Passive Scattering Proton Therapy for Locally Advanced Non-Small Cell Lung Cancer.
    Palma G; Monti S; Xu T; Scifoni E; Yang P; Hahn SM; Durante M; Mohan R; Liao Z; Cella L
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1124-1132. PubMed ID: 30822531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of dose dependency for radiation pneumonitis after chemoradiotherapy with the use of tomotherapy for lung cancer.
    Masuoka Y; Tada T; Tokunaga M; Takeshita N; Terashima M; Tsutsumi S; Ishii K; Shibuya K
    Nagoya J Med Sci; 2022 Feb; 84(1):180-184. PubMed ID: 35392013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy: in regard to Song et al.
    Mehta MP; Khuntia D
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1281; author reply 1281-2. PubMed ID: 20970038
    [No Abstract]   [Full Text] [Related]  

  • 39. Dosimetry and Biochemical Comparison of Early Radiation-Induced Lung Toxicity in Breast Cancer Patients Treated with 3D-CRT and IMRT: the Role of Serum Interleukin-6 and Pulmonary Surfactant Protein-D.
    Mahmoud Hewala TI; El-Benhawy SA; Elwany YN; Hammoury SI; Saeda MA
    Asian Pac J Cancer Prev; 2024 May; 25(5):1707-1713. PubMed ID: 38809643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy.
    Ramella S; Trodella L; Mineo TC; Pompeo E; Stimato G; Gaudino D; Valentini V; Cellini F; Ciresa M; Fiore M; Piermattei A; Russo P; Cesario A; D'Angelillo RM
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):110-5. PubMed ID: 19619955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.